Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Cancer Sci
References Wang Y, Lin J, Yu Z, Cheng J, Cheng J, Cui W
These patients achieved a median PFS of 8.2 months with alpelisib plus fulvestrant or letrozole
The oral formulation tested in the Phase IIb trial used doses of 1 to 20 mg daily [3]
Moving forward, well-designed clinical trials, standardized protocols for strain selection and dosage, and regulatory harmonization will be essential for translating laboratory findings into effective interventions
US$ 27.53
US$ 28.18
US$ 20.63
US$ 28.76
US$ 23.23
US$ 25.36
US$ 20.06
US$ 22.93
US$ 23.91
US$ 24.32
